Pfizer Tshuag poob txawm tias CDC Cov Lus Qhia Tshiab Rau Covid Boosters

Pfizer cov khoom lag luam txuas ntxiv ob hnub dhia dej hnub Tuesday txawm tias tom qab Lub Chaw Tiv Thaiv Kab Mob thiab Tiv Thaiv tau luv lub qhov rais rau nws cov Covid booster rau tsib lub hlis.




X



Qhov kev txiav txim siab CDC cuam tshuam rau txhua tus neeg tau txais Pfizer (PFE) thiab BioNTech (BNTX) tshuaj tiv thaiv. Yav dhau los, lub koob tshuaj tau tso cai rau rau lub hlis tom qab cov neeg tau txais kev pab ua tiav lawv thawj ob koob tshuaj. Cov neeg txais kev pab Niaj hnub (MRNA) thiab Johnson & Johnson (JNJ) cov tshuaj tiv thaiv tuaj yeem tau txais kev txhawb nqa ntawm rau lub hlis thiab ob lub hlis, raws li.

Ntxiv mus, tam sim no CDC yuav tso cai rau cov neeg muaj hnub nyoog 5-11 xyoo tau txais koob thib peb ntawm cov tshuaj tiv thaiv Covid los ntawm Pfizer thiab BioNTech 28 hnub tom qab lawv thib ob.

Tab sis ntawm kev ua lag luam Tshuag hnub no, Pfizer Tshuag poob 3.7% rau 54.53. Shares ntawm nws tus khub, BioNTech, kuj poob 3.4% rau 224.09.

Pfizer Tshuag: Kev taw qhia tshiab rau Boosters

Cov kev taw qhia kev hloov pauv tuaj raws li omicron variant rips los ntawm Teb Chaws Asmeskas

Raws li CDC, qhov hloov pauv tshiab tam sim no suav nrog ntau dua 95% ntawm cov neeg mob hauv lub tebchaws. Delta, qhov kev hloov pauv dhau los, suav nrog tsawg dua 5% ntawm cov neeg mob niaj hnub no. Omicron's spike protein muaj kev hloov pauv uas pab nws tshem tawm cov tshuaj tiv thaiv kab mob uas tsim los ntawm cov tshuaj tiv thaiv thiab / lossis kab mob yav dhau los.

Hnub Monday, Lub Chaw Tswj Xyuas Khoom Noj thiab Tshuaj tau kos npe tawm ntawm Pfizer / BioNTech koob txhaj tshuaj rau cov hluas hnub nyoog 12-15. CDC pawg neeg tawm tswv yim yuav tham txog qhov teeb meem no rau hnub Wednesday. Yog tias ua tiav, qhov kev txhaj tshuaj thib peb tuaj yeem tso tawm rau hnub tom ntej mus rau lub lis piam. Txawm li cas los xij, Pfizer Tshuag tau poob qis hauv lub lis piam tsis ntev los no.

"Ua raws li FDA tau tso cai, cov lus pom zoo niaj hnub no ua kom cov tib neeg tuaj yeem tau txais kev txhawb nqa kev tiv thaiv nyob rau hauv lub ntsej muag ntawm Omicron thiab nce kis thoob plaws hauv lub tebchaws, thiab xyuas kom meej tias cov menyuam yaus uas raug mob feem ntau tuaj yeem tau txais koob tshuaj ntxiv los txhim kho kev tiv thaiv Covid-19, "CDC Tus Thawj Coj Rochelle Walensky tau hais hauv tsab ntawv sau tseg.

Tab sis ua raws li cov xov xwm hnub Monday, Pfizer Tshuag poob ntau dua 4%. BioNTech shares kuj poob rau sab qaum teb ntawm 10%.

Highly Rated Pharma Tshuag

Pfizer Tshuag tseem zoo dua nws qhov kev hloov pauv tseem ceeb, raws li MarketSmith.com.

Shares muaj ib tug txheeb ze lub zog ntsuam xyuas ntawm 96 tawm ntawm qhov zoo tshaj plaws-muaj peev xwm 99. Qhov no txhais tau tias Pfizer Tshuag pauv nyob rau hauv tus thawj 4% ntawm tag nrho cov stocks nyob rau hauv cov nqe lus ntawm 12-lub hlis kev ua tau zoo, IBD Digital qhia.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

FDA tso cai Covid Boosters Rau Cov Hluas Hluas; Tab sis Cov Tshuaj Tiv Thaiv Kab Mob Crumble

BridgeBio Pharma Tshuag Crashes Raws li Pfizer-Rivaling Heart Drug Flops

Tau Nyiaj Los Ntawm Txij Lub Sij Hawm Luv Nrog SwingTrader

Nrhiav Kom Tom Ntej Kua Los Yog Amazon? Pib Nrog Cov S&P 500-Npav Npe

Saib IBD Cov Lus Qhia Txog Kev nqis peev qhia rau Kev Ua Lag Luam Kev Pom Zoo

Tau qhov twg los: https://www.investors.com/news/technology/pfizer-stock-topples-despite-new-cdc-guidance-for-covid-boosters/?src=A00220&yptr=yahoo